The Bayer-Santos Lab, along with researchers at the University of São Paulo, have discovered salmonella toxins that could lead to healthier microbiomes and new targetted antibacterial therapies. See: cns.utexas.edu/news/researc...

Hantaviruses kill nearly 40% of those infected and there’s no approved treatment or vaccine, making them a concern for future pandemics. The most detailed 3D map yet of a key protein complex on the virus might yield new treatments. cns.utexas.edu/news/researc...

A new approach called “epimodulation” — developed by UT Austin researchers & collaborators — predicts epidemic peaks better than current models and could boost health care preparations in future outbreaks. #Epidemiology #PublicHealth @texas-ib.bsky.social cns.utexas.edu/news/researc...

Researchers in the Davies Lab at UT and NIH reveal the first high-res structure of a microcin binding its bacterial receptor—offering more insight in fighting drug-resistant infections. Learn more: lcid.utexas.edu/news/researc...

Congratulations to LCID member Dr. Jason McLellan on receiving a 2025 MacArthur Fellowship for his groundbreaking work in structural biology and infectious disease interventions! cns.utexas.edu/news/accolad...

LCID member Dr. Bryan Davies and his lab have found a new method to help antibodies kill bacteria. Their paper in the journal PNAS describes how: lcid.utexas.edu/news/researc...

SAVE THE DATE: Dr. Vincent Young, MD, PhD, to present the 2025 Richard Meyer Lecture on Nov. 11. lcid.utexas.edu/events/vince...

Recently published article from the Davies Lab shows wide diversity of microcins that may one day aid in the fight against antibiotic resistance.

Dr. Grace Kago, researcher in the Payne Lab, recently had her e-learning community that translates science into Kikuyu, a Central Kenyan language, included in UNESCO’s Open and Inclusive Science Hub. For more, see lcid.utexas.edu/news/announc...